10 results on '"Marzullo, Andrea"'
Search Results
2. VEGFA and VEGFR2 RNAscope determination in gastric cancer
- Author
-
Tamma, Roberto, Annese, Tiziana, Ruggieri, Simona, Marzullo, Andrea, Nico, Beatrice, and Ribatti, Domenico
- Published
- 2018
- Full Text
- View/download PDF
3. PRAME Immuno-Expression in Cutaneous Sebaceous Carcinoma: A Single Institutional Experience.
- Author
-
Cazzato, Gerardo, Colagrande, Anna, Ingravallo, Giuseppe, Lettini, Teresa, Filoni, Angela, Ambrogio, Francesca, Bonamonte, Domenico, Dellino, Miriam, Lupo, Carmelo, Casatta, Nadia, Resta, Leonardo, Maiorano, Eugenio, Cascardi, Eliano, and Marzullo, Andrea
- Subjects
SEBACEOUS gland diseases ,SKIN cancer ,IMMUNOSTAINING ,DIFFERENTIAL diagnosis ,STATISTICAL significance ,MELANOMA - Abstract
Background: In recent years, great research interest has been directed to the diagnostic, therapeutic and marker role of Preferentially expressed Antigen in Melanoma (PRAME) in the setting of various human neoplasms. Although it has been extensively studied mainly in the differential diagnosis setting of melanocytic pigmented lesions, still very few papers have analyzed the usefulness or otherwise of PRAME in the context of other non-melanoma skin cancers (NMSC). (2) Methods: In this paper, we report the data of our experience of 21 cases of sebaceous carcinoma (SC) classified in the three WHO grade and collected in the period between January 2005 and 31 October 2022, on which immunostaining for PRAME was performed; Non-parametric Mann–Whitney test for non-normally distributed values was performed. A comparison was made of the means between the three study groups (grade I, II and III). A value of p ≤ 0.05 was set as statistically significant (3) Results: Only seven cases (33.3%) were positive with an immunoscore of 2+/3+ for intensity and 1+/2+ for percentage cells positivity, while 14 cases (66.6%) were totally or nearly totally negative for PRAME with a few of sebaceous-like cells positive with an immunoscore of 1+. Eight cases of SC grade I were immunostaining for PRAME, a level of the cytoplasm of foci of sebaceous differentiation with a significant statical value (p < 0.0001) with respect to ten cases of SC grade II; furthermore, the eight cases of grade I were positive for PRAME in the same areas respect the 3 cases of SC grade III (p = 0.0303). There were no statistical significance between the 10 cases of grade II and 3 cases of grade III (p = 0.2028); (4) Conclusions: PRAME not seems to add particular information in the case of histopathological diagnostics of SC where other markers, including adipophylline, can be quite indicative. It seems, on the other hand, that PRAME can be useful in the subclassification setting of sebaceous carcinoma in grades I–II–III according to the directives of the latest WHO 2018, highlighting the foci of mature sebaceous differentiation most present in grades 1–2 and almost completely absent in grade 3 of the SC. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Polymorphic Malignant Melanoma (PMM) of the Left Helix: Case Report with Clinical-Pathological Correlations.
- Author
-
Cazzato, Gerardo, Colagrande, Anna, Maruccia, Michele, Nacchiero, Eleonora, Lupo, Carmelo, Casatta, Nadia, Ingravallo, Giuseppe, Maiorano, Eugenio, Marzullo, Andrea, Giudice, Giuseppe, and Resta, Leonardo
- Subjects
MELANOMA ,BRAF genes ,DIAGNOSTIC errors ,GENETIC mutation ,DERMATOPATHOLOGY ,REVERSE transcriptase polymerase chain reaction - Abstract
Malignant melanoma (MM) is known to be the great mimic in dermatopathology. Over time, several variants have been described, not all of which have repercussions on the clinical/oncological management of the affected patient. The existence, however, of these alternative forms of MM is of great interest to the pathologist, as they are potentially capable of inducing diagnostic errors affecting the diagnostic-therapeutic care pathway (PDTC). In this paper, we present a very rare case of polymorphic MM, in which five different morphological aspects coexisted in the same lesion, confirmed by immunohistochemical investigation and by RT-PCR for mutation of the BRAF gene and discuss the importance of correct recognition of these different morphological features to avoid misdiagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. Kikuchi-Fujimoto disease: an uncommon cause of neck swelling.
- Author
-
Fiorella, Maria, Gelardi, Matteo, Fiorella, Raffaele, Marzullo, Andrea, and Sabattini, Elena
- Subjects
LYMPH node diseases ,IMMUNOHISTOCHEMISTRY ,BLOOD sedimentation ,THERAPEUTICS - Abstract
Kikuchi-Fujimoto's disease (KFD) is a rare, benign condition characterized by histiocytic necrotizing lymphadenitis predominantly in the cervical region and prolonged fever. It has a higher prevalence in the Japanese and Asian populations although it may be seen in a wide geographic distribution, but rare are the cases reported in Europe. While symptoms resolve spontaneously between 2 weeks and 2 months, complications are described in: CNS, eyes, respiratory tract, kidney and liver. KFD also described an association with systemic lupus erythematosus. This paper describes a rare case of Kikuchi-Fujimoto lymphadenitis and discusses the features of the disease. A 24-year-old man presented with fever and a swollen 3-cm lymph node in the left side of the neck. The definitive diagnosis was established, after excision of level VB nodes on the left, by histologic examination. It revealed structurally intact tissue with scalloping in the paracortical area presenting activated T cells, focal monocytoid B cells, sinus histiocytosis and normally polarized follicles. Other two samples presented focal alterations of the tissue structure due to broad areas of necrosis, conspicuous nuclear debris, large lymphoid cells as well as numerous histiocytes. Immunohistochemistry revealed CD3+ and CD8+ T lymphocytes and histiocytes expressing CD68/PGM-1 (specific for macrophage lineage) and myeloperoxidase (MPO, specific for myeloid lineage). Correct, prompt diagnosis should be established through the findings of imaging and pathologic studies to avoid unnecessary investigation and ineffective therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. An immunohistochemical study on the neurotensinergic system in the human dentate nucleus.
- Author
-
Flace, Paolo, Galletta, Diana, Coviello, Vincenzo, Fata, Giulio, Veneziani, Biagio, Di Lernia, Maria Giovanna, Bizzoca, Antonella, Gennarini, Gianfranco, Anastasi, Giuseppe, Marzullo, Andrea, and Quartarone, Angelo
- Abstract
The article focuses on the discovery of an intrinsic neurotensinergic neuronal system in the human dentate nucleus, suggesting its potential role in neuromodulation mechanisms of cerebellar circuits and its implications for dopamine-related brain disorders.
- Published
- 2023
7. Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations.
- Author
-
Rizzo, Francesca Maria, Palmirotta, Raffaele, Marzullo, Andrea, Resta, Nicoletta, Cives, Mauro, Tucci, Marco, and Silvestris, Franco
- Subjects
GENE expression ,GASTROINTESTINAL stromal tumors ,CANCER relapse ,GENETIC mutation ,PLATELET-derived growth factor receptors ,IMMUNOHISTOCHEMISTRY - Abstract
Background: Gastrointestinal stromal tumors (GISTs) are characterized by mutations of KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) or PDGFRA (platelet-derived growth factor receptor α) that may be efficiently targeted by tyrosine kinase inhibitors (TKI). Notwithstanding the early responsiveness to TKI, the majority of GISTs progress, imposing the need for alternative therapeutic strategies. DOG1 (discovered on GIST-1) shows a higher sensitivity as a diagnostic marker than KIT, however its prognostic role has been little investigated. Methods: We evaluated DOG1 expression by immunohistochemistry (IHC) in 59 patients with GISTs, and correlated its levels with clinical and pathological features as well as mutational status. Kaplan-Meier analysis was also applied to assess correlations of the staining score with patient recurrence-free survival (RFS). Results: DOG1 was expressed in 66 % of CD117
+ GISTs and highly associated with tumor size and the rate of wildtype tumors. Kaplan-Meier survival analysis showed that a strong DOG1 expression demonstrated by IHC correlated with a worse 2-year RFS rate, suggesting its potential ability to predict GISTs with poor prognosis. Conclusions: These findings suggest a prognostic role for DOG1, as well as its potential for inclusion in the criteria for risk stratification. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
8. Immune Disregulation in Cutaneous Squamous Cell Carcinoma of Patients with Recessive Dystrophic Epidermolysis Bullosa: A Single Pilot Study.
- Author
-
Filoni, Angela, Cicco, Gerolamo, Cazzato, Gerardo, Bosco, Anna, Lospalluti, Lucia, Tucci, Marco, Cimmino, Antonietta, Foti, Caterina, Marzullo, Andrea, and Bonamonte, Domenico
- Subjects
SQUAMOUS cell carcinoma ,EPIDERMOLYSIS bullosa ,T cells ,CYTOTOXIC T cells ,IMMUNOHISTOCHEMISTRY ,LYMPHOCYTE count ,PILOT projects ,T helper cells - Abstract
Background: Cutaneous squamous cell carcinoma (cSCC) is one of the most devastating complications of recessive dystrophic epidermolysis bullosa (RDEB). We recently demonstrated a reduction in immune cell peritumoral infiltration in RDEB patients with cSCC, together with a reduction in CD3+, CD4+, CD68+ and CD20 lymphocytes as compared to primary and secondary cSCC in patients without RDEB. Recently, new molecules, such as high mobility group box 1 (HMGB1), T cell immunoglobulin, mucin domain 3 (TIM-3) and Heme oxygenase-1 (HO-1), have been shown to play a role in antitumoral immunity. Objective: Patients with RDEB are known to be at increased risk of developing skin cancers, including the dreaded squamous cell carcinoma of the. Tendentially, cSCCs that arise in the context of EBDR are more aggressive and lead to statistically significant bad outcomes compared to cSCCs developed on the skin of patients without EBDR. In an attempt to study the microenvironment of these lesions, we conducted an immunohistochemical analysis study of proteins that could be actively involved in the genesis of this type of malignant neoplasms. Methods: In this retrospective study, the OH1-HMGB1-TIM3 activation axis, as correlated to the T lymphocytes cell count, was assessed in biopsy samples from 31 consecutive cases consisting of 12 RDEB patients with cSCC, 12 patients with primary cSCC and 7 RDEB patients with pseudoepitheliomatous cutaneous hyperplasia. Parametric Student's t-test was applied for normally distributed values, such as CD4+ and CD8+, and non-parametric Mann–Whitney test for non-normally distributed values, such as HMGB-1, TIM-3 and HO-1. Results: In RDEB patients with cSCC and with pseudoepitheliomatous hyperplasia, the expression of CD4 T helper lymphocytes was lower than in the peritumoral infiltrate found in primary cSCC. CD8 cytotoxic T lymphocytes were increased in primary cSCC compared to the other two groups. An increased HMGB1 expression was evident in both primary and RDEB cSCC. TIM3 expression was higher in RDEB patients with cSCC compared to the other two groups. A significantly reduced immunohistochemical expression of HO-1 was evident in the tumoral microenvironment of cSCC-RDEB as compared to primary cSCC. Conclusions: These data suggest that a reduced immune cell peritumoral infiltration in RDEB patients could be responsible, in the complexity of the mechanisms of carcinogenesis and host response, of the particular aggressiveness of the cSCC of RDEB patients, creating a substrate for greater local immunosuppression, which, potentially, can "open the doors" to development and eventual metastasis by this malignant neoplasm. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Author's reply on letter to editor "Apocrine carcinoma is the fact" by Vranic S.
- Author
-
Gurrado, Angela, Serio, Gabriella, and Marzullo, Andrea
- Subjects
CANCER diagnosis ,BREAST tumors ,IMMUNOHISTOCHEMISTRY ,SWEAT gland diseases - Published
- 2020
- Full Text
- View/download PDF
10. Caspase 3 and 8 deficiency in human neuroblastoma
- Author
-
Iolascon, Achille, Borriello, Adriana, Giordani, Lucia, Cucciolla, Valeria, Moretti, Arcangela, Monno, Fausta, Criniti, Vittoria, Marzullo, Andrea, Criscuolo, Maria, and Ragione, Fulvio Della
- Subjects
- *
TUMORS , *DRUG therapy , *IMMUNOHISTOCHEMISTRY , *CELL lines - Abstract
An altered apoptotic response represents a pivotal feature of cancer and is involved in cancerogenesis and resistance to chemotherapy. So far, however, only a few studies have been devoted to survey caspase content in malignant cell lines and primary tumor specimens. In this report, we investigated the expression of two pivotal caspases, 3 and 8, in 63 neuroblastoma specimens by three complementary techniques (i.e., reverse transcriptase polymerase chain reaction, immunoblotting, and immunohistochemistry). We confirmed the frequent absence of caspase 8 expression. Moreover and most important, we demonstrated, for the first time to our knowledge, that a significant percentage of neuroblastomas lack caspase 3 mRNA and protein. Both caspase alterations do not show any correlation with tumor stage and MYCN status. Immunohistochemistry showed a large number of caspase-negative cell islets also present in positive samples. Our findings suggest that the absence of caspases might play an important role in neuroblastoma development and resistance to apoptosis-based treatments. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.